Trial Profile
Clinical Trials Insight: 700020778
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 08 Feb 2007
Price :
$35
*
At a glance
- Drugs RPI-MN (Primary)
- Indications Herpes genitalis; Viral infections
- Focus Therapeutic Use
- Sponsors Receptopharm
- 08 Feb 2007 New trial record.